BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,469 | -48.0% | 10,823 | -37.3% | 0.02% | -45.2% |
| Q2 2023 | $785,921 | -4.5% | 17,250 | -14.9% | 0.04% | -12.5% |
| Q1 2023 | $822,607 | +93.9% | 20,281 | +143.6% | 0.05% | +77.8% |
| Q4 2022 | $424,286 | -31.5% | 8,324 | -27.6% | 0.03% | -38.6% |
| Q3 2022 | $619,000 | -1.7% | 11,493 | +17.2% | 0.04% | +2.3% |
| Q2 2022 | $630,000 | -30.2% | 9,808 | -15.7% | 0.04% | -17.3% |
| Q1 2022 | $902,000 | -9.3% | 11,637 | +0.5% | 0.05% | -7.1% |
| Q4 2021 | $994,000 | +8.6% | 11,580 | +1.8% | 0.06% | 0.0% |
| Q3 2021 | $915,000 | -3.1% | 11,380 | -2.9% | 0.06% | -3.4% |
| Q2 2021 | $944,000 | -3.7% | 11,722 | +0.9% | 0.06% | -22.7% |
| Q1 2021 | $980,000 | -3.3% | 11,617 | -8.0% | 0.08% | +8.7% |
| Q4 2020 | $1,013,000 | +2.4% | 12,628 | +2.6% | 0.07% | -21.6% |
| Q3 2020 | $989,000 | -9.3% | 12,309 | -2.8% | 0.09% | -14.6% |
| Q2 2020 | $1,091,000 | +10.4% | 12,670 | +4.1% | 0.10% | -7.2% |
| Q1 2020 | $988,000 | -0.4% | 12,171 | +2.6% | 0.11% | +13.3% |
| Q4 2019 | $992,000 | -10.0% | 11,864 | -5.8% | 0.10% | -14.8% |
| Q3 2019 | $1,102,000 | +5.5% | 12,596 | -1.3% | 0.12% | +0.9% |
| Q2 2019 | $1,045,000 | +6.4% | 12,762 | +5.7% | 0.11% | -6.6% |
| Q1 2019 | $982,000 | +28.9% | 12,077 | +4.3% | 0.12% | +13.0% |
| Q4 2018 | $762,000 | -16.9% | 11,574 | -2.7% | 0.11% | -4.4% |
| Q3 2018 | $917,000 | +6.3% | 11,898 | +1.8% | 0.11% | -3.4% |
| Q2 2018 | $863,000 | +13.1% | 11,687 | -0.4% | 0.12% | +11.4% |
| Q1 2018 | $763,000 | -4.9% | 11,737 | -5.4% | 0.10% | -5.4% |
| Q4 2017 | $802,000 | +30.6% | 12,408 | +26.8% | 0.11% | +22.0% |
| Q3 2017 | $614,000 | +7.9% | 9,785 | +4.1% | 0.09% | -6.2% |
| Q2 2017 | $569,000 | +17.3% | 9,404 | +0.5% | 0.10% | +11.5% |
| Q1 2017 | $485,000 | +29.3% | 9,353 | +10.5% | 0.09% | +19.2% |
| Q4 2016 | $375,000 | -7.6% | 8,467 | -0.7% | 0.07% | -11.0% |
| Q3 2016 | $406,000 | +5.5% | 8,523 | +0.1% | 0.08% | -3.5% |
| Q2 2016 | $385,000 | +11.3% | 8,517 | +1.1% | 0.08% | +3.7% |
| Q1 2016 | $346,000 | +24.9% | 8,428 | +16.1% | 0.08% | +24.2% |
| Q4 2015 | $277,000 | +6.5% | 7,262 | -8.4% | 0.07% | -1.5% |
| Q3 2015 | $260,000 | -48.7% | 7,926 | +9.3% | 0.07% | -45.1% |
| Q2 2015 | $507,000 | +12.2% | 7,251 | +9.8% | 0.12% | +10.9% |
| Q1 2015 | $452,000 | -7.8% | 6,602 | -1.2% | 0.11% | -10.6% |
| Q4 2014 | $490,000 | -4.7% | 6,682 | -6.7% | 0.12% | -14.0% |
| Q3 2014 | $514,000 | +13.7% | 7,160 | +14.5% | 0.14% | +11.7% |
| Q2 2014 | $452,000 | +14.7% | 6,252 | +16.7% | 0.13% | +13.3% |
| Q1 2014 | $394,000 | +1.3% | 5,358 | -4.2% | 0.11% | +1.8% |
| Q4 2013 | $389,000 | -5.1% | 5,590 | -10.4% | 0.11% | -13.3% |
| Q3 2013 | $410,000 | -2.4% | 6,240 | +3.1% | 0.13% | -12.3% |
| Q2 2013 | $420,000 | – | 6,052 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |